Variant report
Variant | esv2760256 |
---|---|
Chromosome Location | chr12:41525540-41542361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56252901 | chr12:41533403-41533404 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs534234558 | chr12:41533405-41533406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559452259 | chr12:41533452-41533453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75748361 | chr12:41533466-41533467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560641174 | chr12:41533529-41533530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564257626 | chr12:41533567-41533568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186031504 | chr12:41533661-41533662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546815995 | chr12:41533699-41533700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79126840 | chr12:41533739-41533740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532303301 | chr12:41533764-41533765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113685327 | chr12:41533794-41533795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550483485 | chr12:41533798-41533799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35999552 | chr12:41533819-41533820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568480156 | chr12:41533835-41533836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535847390 | chr12:41533857-41533858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554365329 | chr12:41533871-41533872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369575102 | chr12:41533913-41533914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566600886 | chr12:41533943-41533944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs151328950 | chr12:41533961-41533962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559131279 | chr12:41533972-41533973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs776560 | chr12:41533983-41533984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs118034366 | chr12:41534008-41534009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556902289 | chr12:41534037-41534038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146434230 | chr12:41534052-41534053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574840855 | chr12:41534108-41534109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140672008 | chr12:41534117-41534118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560375066 | chr12:41534121-41534122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527822949 | chr12:41534156-41534157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144589268 | chr12:41534159-41534160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565064706 | chr12:41534175-41534176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532191181 | chr12:41534257-41534258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550421436 | chr12:41534303-41534304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569290301 | chr12:41534318-41534319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191131904 | chr12:41534338-41534339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375321094 | chr12:41534343-41534344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs776561 | chr12:41534359-41534360 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs548202060 | chr12:41534419-41534420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76478064 | chr12:41534421-41534422 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182031395 | chr12:41534472-41534473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187643140 | chr12:41534589-41534590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533855398 | chr12:41534621-41534622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs386762427 | chr12:41534631-41534632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs60209215 | chr12:41534632-41534633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146675434 | chr12:41534643-41534644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs113380604 | chr12:41534656-41534657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575249358 | chr12:41534674-41534675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541844528 | chr12:41534724-41534725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548743319 | chr12:41534784-41534785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554166226 | chr12:41534787-41534788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572372415 | chr12:41534843-41534844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 20858243 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:41533400-41534400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr12:41533400-41534600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr12:41533600-41534200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr12:41533600-41534400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr12:41533600-41534800 | Enhancers | Colon Smooth Muscle | Colon |
6 | chr12:41533800-41534200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr12:41533800-41534400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr12:41533800-41534400 | Enhancers | HUVEC | blood vessel |
9 | chr12:41533800-41536200 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr12:41534000-41534600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr12:41534200-41535200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr12:41534400-41534800 | Enhancers | Aorta | Aorta |
13 | chr12:41534800-41535200 | Weak transcription | Colon Smooth Muscle | Colon |
14 | chr12:41534800-41538600 | Weak transcription | Aorta | Aorta |
15 | chr12:41535200-41535400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr12:41535200-41535800 | Enhancers | Colon Smooth Muscle | Colon |
17 | chr12:41538600-41539000 | Enhancers | Aorta | Aorta |
18 | chr12:41539000-41540200 | Weak transcription | Aorta | Aorta |
19 | chr12:41540400-41540600 | Enhancers | Aorta | Aorta |